111 related articles for article (PubMed ID: 11425459)
21. Jumping translocation of homogeneously staining region and tetraploidy with double minutes in acute myelomonocytic leukemia.
Yoshida T; Kimura N; Akiyoshi T; Ohshima K; Nagano M; Morioka E; Hisano S; Ohyashiki K; Kamada N; Tamura K
Cancer Genet Cytogenet; 1999 Feb; 109(1):40-4. PubMed ID: 9973958
[TBL] [Abstract][Full Text] [Related]
22. A rare case with typical acute promyelocytic leukemia morphology associated with isolated isochromosome 17q without RARα rearrangement.
Duan Y; Nie J; Zhang Z; Zhou L; Zhu F; Zhang H; Zhu H; Shang W
Hematol Oncol Stem Cell Ther; 2013 Mar; 6(1):42-5. PubMed ID: 23664605
[TBL] [Abstract][Full Text] [Related]
23. 5'RARA submicroscopic deletion from new variant translocation involving chromosomes 15, 17, and 18, in a case of acute promyelocytic leukemia.
Stavropoulou C; Georgakakos VN; Manola KN; Pagoni M; Garofalaki M; Pantelias GE; Sambani C
Cancer Genet Cytogenet; 2008 Apr; 182(1):50-5. PubMed ID: 18328952
[TBL] [Abstract][Full Text] [Related]
24. Abnormal dicentric chromosome with co-amplification of sequences from chromosomes 11 and 19: a novel rearrangement in a patient with myelodysplastic syndrome transforming to acute myeloid leukemia.
Smith A; Heaps LS; Sharma P; Jarvis A; Forsyth C
Cancer Genet Cytogenet; 2001 Oct; 130(1):29-32. PubMed ID: 11672770
[TBL] [Abstract][Full Text] [Related]
25. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
Slack JL; Arthur DC; Lawrence D; Mrózek K; Mayer RJ; Davey FR; Tantravahi R; Pettenati MJ; Bigner S; Carroll AJ; Rao KW; Schiffer CA; Bloomfield CD
J Clin Oncol; 1997 May; 15(5):1786-95. PubMed ID: 9164186
[TBL] [Abstract][Full Text] [Related]
26. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
Fonatsch C; Gudat H; Lengfelder E; Wandt H; Silling-Engelhardt G; Ludwig WD; Thiel E; Freund M; Bodenstein H; Schwieder G
Leukemia; 1994 Aug; 8(8):1318-26. PubMed ID: 8057667
[TBL] [Abstract][Full Text] [Related]
27. Therapy-related myelodysplastic syndrome after eradication of acute promyelocytic leukemia: cytogenetic and molecular features.
Au WY; Lam CC; Ma ES; Man C; Wan T; Kwong YL
Hum Pathol; 2001 Jan; 32(1):126-9. PubMed ID: 11172306
[TBL] [Abstract][Full Text] [Related]
28. The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization study.
Hicks DG; Yoder BJ; Pettay J; Swain E; Tarr S; Hartke M; Skacel M; Crowe JP; Budd GT; Tubbs RR
Hum Pathol; 2005 Apr; 36(4):348-56. PubMed ID: 15891995
[TBL] [Abstract][Full Text] [Related]
29. [Marked dysmyelopoiesis after induction chemotherapy in a case of acute myelomonocytic leukemia (M 4) with t(6; 11)].
Tagawa M; Tokunaga K; Kuriyama K; Jinnai I; Yoshida Y; Nonaka H; Sadamori N; Tomonaga M; Ichimaru M
Rinsho Ketsueki; 1989 Feb; 30(2):232-8. PubMed ID: 2746877
[TBL] [Abstract][Full Text] [Related]
30. Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RARalpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3.
Virchis A; Massey E; Butler T; Devaraj P; Wright F; Secker-Walker L; Prentice HG; Mehta A
Br J Haematol; 2001 Sep; 114(3):551-6. PubMed ID: 11552979
[TBL] [Abstract][Full Text] [Related]
31. Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells.
Rondón-Lagos M; Verdun Di Cantogno L; Rangel N; Mele T; Ramírez-Clavijo SR; Scagliotti G; Marchiò C; Sapino A
BMC Cancer; 2014 Dec; 14():922. PubMed ID: 25481507
[TBL] [Abstract][Full Text] [Related]
32. Chromosome 17 centromere duplication and responsiveness to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Tibau A; López-Vilaró L; Pérez-Olabarria M; Vázquez T; Pons C; Gich I; Alonso C; Ojeda B; Ramón y Cajal T; Lerma E; Barnadas A; Escuin D
Neoplasia; 2014 Oct; 16(10):861-7. PubMed ID: 25379022
[TBL] [Abstract][Full Text] [Related]
33. Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.
Bouchalová K; Trojanec R; Kolár Z; Cwiertka K; Cernáková I; Mihál V; Hajdúch M
Neoplasma; 2006; 53(5):393-401. PubMed ID: 17013533
[TBL] [Abstract][Full Text] [Related]
34. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
35. Trisomy 11 and a complex t(11;11;22) in a patient with acute myelomonocytic leukemia (AML-M4) following myelodysplasia (MDS): a cytogenetic study of a mechanism of leukemogenesis.
Bernasconi P; Cavigliano PM; Boni M; Malcovati L; Astori C; Castagnola C; Pagnucco G; Vanelli L; Calatroni S; Caresana M; Lazzarino M; Bernasconi C
Cancer Genet Cytogenet; 2000 Jan; 116(2):111-8. PubMed ID: 10640142
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of i(17q) in metaphase and interphase of malignant hematopoietic cells by fluorescence in situ hybridization.
Shi G; Weh HJ; Hossfeld DK
Cancer Genet Cytogenet; 1994 Mar; 73(1):17-22. PubMed ID: 8174070
[TBL] [Abstract][Full Text] [Related]
37. Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.
Järvinen TA; Tanner M; Rantanen V; Bärlund M; Borg A; Grénman S; Isola J
Am J Pathol; 2000 Mar; 156(3):839-47. PubMed ID: 10702400
[TBL] [Abstract][Full Text] [Related]
38. A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in acute promyelocytic leukemia (APML) with atypical features.
Corey SJ; Locker J; Oliveri DR; Shekhter-Levin S; Redner RL; Penchansky L; Gollin SM
Leukemia; 1994 Aug; 8(8):1350-3. PubMed ID: 8057672
[TBL] [Abstract][Full Text] [Related]
39. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
[TBL] [Abstract][Full Text] [Related]
40. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
